{"id":984,"date":"2016-10-10T00:58:44","date_gmt":"2016-10-10T00:58:44","guid":{"rendered":"http:\/\/hfhpulm.com\/info\/?p=984"},"modified":"2017-06-23T14:16:35","modified_gmt":"2017-06-23T14:16:35","slug":"controlled-substance-scripts-k17","status":"publish","type":"post","link":"https:\/\/hfhpulm.com\/info\/?p=984","title":{"rendered":"Controlled substance scripts from K17"},"content":{"rendered":"

In an effort to improve the care of our patients, reduce redundant phone calls while prescribing physicians are away, and resolve any confusion, I have adapted the guidelines used on K15 (>8 weeks controlled substance script)<\/strong><\/p>\n

<\/p>\n

Applicable to primary prescribers:<\/p>\n

There are a lot of attachments (primarily for those of you who are prescribing recurrent controlled substances).\u00a0 In addition to the controlled substance contract being used, the \u2018medication contract K17\u2019 is also to be provided to patients to provide realistic expectations.\u00a0 \u00a0In clinic assessment of continued script need will be due every 6 months<\/strong> (includes urine toxicology screen).\u00a0 Smartphrase: “.HFNARCOTICMANGEMENT<\/strong>“.\u00a0\u00a0 MAPS are to be run on the patients every 3 months.<\/p>\n

I will be having the nurses ask any primary prescribers to obtain his own MAPS ID (so that every patient isn\u2019t being looked up under my MAPS ID).\u00a0 The nurses can run these reports. \u00a0\u00a0To minimize the time spent by the nurses on the phone and with the patient (which takes away from dealing with ill patients), we will be moving exclusively to electronic scripts.<\/p>\n

I have also attached the NIH recommendations regarding chronic pain management.<\/p>\n

—
\nApplicable to all senior staff:<\/p>\n

Coverage of controlled substance scripts while provider is away (based on K15 practices and NIH recommendations):<\/p>\n